These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 9301545)

  • 61. Interferons and apoptosis.
    Clemens MJ
    J Interferon Cytokine Res; 2003 Jun; 23(6):277-92. PubMed ID: 12859854
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Interfering with interferon receptor sorting and trafficking: impact on signaling.
    Claudinon J; Monier MN; Lamaze C
    Biochimie; 2007; 89(6-7):735-43. PubMed ID: 17493737
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A novel approach for understanding the effects of interferons--a working hypothesis.
    Premecz G; Markovits A; Földes I
    Acta Microbiol Hung; 1987; 34(1):45-55. PubMed ID: 2442954
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Type I interferons: ancient peptides with still under-discovered anti-cancer properties.
    Caraglia M; Dicitore A; Marra M; Castiglioni S; Persani L; Sperlongano P; Tagliaferri P; Abbruzzese A; Vitale G
    Protein Pept Lett; 2013 Apr; 20(4):412-23. PubMed ID: 23016588
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The mechanism of action of interferon.
    Lewis JA
    Horiz Biochem Biophys; 1982; 6():357-84. PubMed ID: 6194098
    [No Abstract]   [Full Text] [Related]  

  • 66. Interferons and cell differentiation.
    Rossi GB
    Interferon; 1985; 6():31-68. PubMed ID: 2410370
    [No Abstract]   [Full Text] [Related]  

  • 67. Species specificity of interferon.
    Gillespie D; Carter WA
    Tex Rep Biol Med; 1981-1982; 41():37-42. PubMed ID: 6184826
    [No Abstract]   [Full Text] [Related]  

  • 68. Interferon redux.
    Friedman RM; Epstein LB; Merigan TC
    Nature; 1982 Apr; 296(5859):704-5. PubMed ID: 6175908
    [No Abstract]   [Full Text] [Related]  

  • 69. Jak-Stat signal transduction pathway through the eyes of cytokine class II receptor complexes.
    Kotenko SV; Pestka S
    Oncogene; 2000 May; 19(21):2557-65. PubMed ID: 10851054
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Antiviral and antiproliferative properties of interferons: mechanism of action.
    Esteban M; Paez E
    Prog Med Virol; 1985; 32():159-73. PubMed ID: 2410953
    [No Abstract]   [Full Text] [Related]  

  • 71. Editorial: Immunoregulatory Mechanisms of Interferon.
    Duerr CU; Fritz JH
    Front Immunol; 2020; 11():187. PubMed ID: 32117309
    [No Abstract]   [Full Text] [Related]  

  • 72. Interferon-gamma: success, structure and speculation.
    Epstein LB
    Nature; 1982 Feb; 295(5849):453-4. PubMed ID: 6173768
    [No Abstract]   [Full Text] [Related]  

  • 73. B.C., D.C., and A.C. of an interferon gene.
    Taniguchi T
    J Interferon Res; 1987 Oct; 7(5):481-5. PubMed ID: 2445844
    [No Abstract]   [Full Text] [Related]  

  • 74. Crystallization of recombinant human leukocyte interferon A.
    Miller DL; Kung HF; Pestka S
    Science; 1982 Feb; 215(4533):689-90. PubMed ID: 6173922
    [No Abstract]   [Full Text] [Related]  

  • 75. Gamma winners.
    Newmark P
    Nature; 1981 Nov; 294(5836):7. PubMed ID: 6169999
    [No Abstract]   [Full Text] [Related]  

  • 76. Interferon.
    Stinebring WR
    Ann N Y Acad Sci; 1977 Mar; 284():666. PubMed ID: 280154
    [No Abstract]   [Full Text] [Related]  

  • 77. Regulation of production of mucosal antibody to pneumococcal protein antigens by T-cell-derived gamma interferon and interleukin-10 in children.
    Zhang Q; Bernatoniene J; Bagrade L; Paton JC; Mitchell TJ; Hammerschmidt S; Nunez DA; Finn A
    Infect Immun; 2006 Aug; 74(8):4735-43. PubMed ID: 16861661
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Role of tumor necrosis factor-related apoptosis-inducing ligand in immune response to influenza virus infection in mice.
    Ishikawa E; Nakazawa M; Yoshinari M; Minami M
    J Virol; 2005 Jun; 79(12):7658-63. PubMed ID: 15919918
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Sensitivities of human monocytes and epithelial cells to pneumolysin are different.
    Hirst RA; Yesilkaya H; Clitheroe E; Rutman A; Dufty N; Mitchell TJ; O'Callaghan C; Andrew PW
    Infect Immun; 2002 Feb; 70(2):1017-22. PubMed ID: 11796644
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Type I interferons (IFNs) regulate tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression on human T cells: A novel mechanism for the antitumor effects of type I IFNs.
    Kayagaki N; Yamaguchi N; Nakayama M; Eto H; Okumura K; Yagita H
    J Exp Med; 1999 May; 189(9):1451-60. PubMed ID: 10224285
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.